Grifols gains global rights to Aradigm's Pulmaquin

Grifols gains global rights to Aradigm's Pulmaquin
23 May 2013. Search. The Pharma Letter · Home · 7 Day Premium Trial · Pharmaceuticals · Biotechnology · Generics · Events · Companies · Drugs · Subscribe. Keywords: Grifols, Aradigm, Pulmaqun, Inhaled ciprofloxacin, Global rights, Equity stake option …
Read more on The Pharma Letter

AVEVA growth will get nuclear charge
Powered By T3 Framework. Copyright © 2013 Business Weekly | Technology | Biotechnology | Business news | Cambridge and the East of England. All Rights Reserved. Designed by Joomla! is Free Software released under the GNU/GPL …
Read more on Business Weekly

Buckingham biotechnology company raises .6 million
Callidus Biopharma, a development-stage company headquartered at the Pennsylvania Biotechnology Center in Buckingham, has closed on $ 4.6 million in financing. The funding will help Callidus accelerate the pre-clinical development of therapies for …

This entry was posted in Biotechnology and tagged , , , , , . Bookmark the permalink.

Leave a Reply